Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasms × Skin Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphedema 1 Breast Neoplasms 1

Interventions

Trastuzumab 502 Paclitaxel 473 Cyclophosphamide 464 Docetaxel 412 Capecitabine 342 Letrozole 294 Fulvestrant 257 Doxorubicin 241 Carboplatin 228 Tamoxifen 215 Anastrozole 181 Radiotherapy 175 exemestane 173 Epirubicin 171 Bevacizumab 161 Lapatinib 144 Vinorelbine 139 pertuzumab 137 pembrolizumab 137 Gemcitabine 137 palbociclib 122 Exercise 109 Magnetic Resonance Spectroscopy 101 Fluorouracil 101 Albumin-Bound Paclitaxel 99 eribulin 95 130-nm albumin-bound paclitaxel 87 Everolimus 85 Cisplatin 80 Taxes 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02609724 2022-03-17

EFforT-BCRL

Universitaire Ziekenhuizen KU Leuven

Phase NA Completed

194 enrolled 19 charts

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡